Nerve Disorder
REUTERS Europe's medicines regulator has added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side-effect of AstraZeneca's (AZN.L) COVID-19...
Europe's medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson's (JNJ.N) COVID-19 vacc...
Qatar Secures Place Among the World's Top 10 Wealthiest Nations
Hamad International Airport Witnesses Record Increase in Passenger Traffic
Saudi Arabia: Any visa holder can now perform Umrah
What are Qatar's Labour Laws on Annual Leave?